Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA
Recruiting · NCT06157060 · Registry updated 2026-03-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA | Hepatocellular Carcinoma Resectable | Recruiting | Not stated | 2026-03-20 | NCT06157060 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhujiang Hospital | 82 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Cancer Hospital and Institute of Guangzhou Medical University | Guangzhou | China | 6 |
| Guangdong Provincial Hospital of Traditional Chinese Medicine | Guangzhou | China | 8 |
| Shunde Hospital of Southern Medical University | Guangzhou | China | 1 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 113 |
| The Sixth Affiliated Hospital of South China University of Technology | Foshan | China | 3 |
| Yuebei People's Hospital | Shaoguan | China | 8 |
| Zhujiang Hospital of Southern Medical University | Guangzhou | China | 4 |